Antibodies, detection systems and accessories for immunohistochemistry
Probes, kits and detection systems – visualizing DNA and RNA in tissue sections
Real-time PCR, Next Generation Sequencing (NGS) and DNA arrays – careful analysis, reliable detection
Staining machines for immunohistochemistry and a machine for in-situ hybridisation
Complete blocks, slide sets and individual tissue arrays – for routine and research
We are a Berlin-based company specializing in the development, manufacture and distribution of diagnostic reagents and system solutions for immunohistology, in situ hybridization and molecular pathology.
Consistent high quality is a top priority. This is why development and manufacturing of our products are governed by a quality management system certified to ISO 9001:2015 and ISO 13485:2016. A majority of the Zytomed Systems products are CE labelled and are approved as reagents for in vitro purposes (CE/IVD). See the download section for our certificates.
At Zytomed Systems we will be also compliant with the IVDR requirements.
Learn moreEthically correct, respectful dealing with our business partners is of very high importance to Zytomed Systems GmbH and a matter of course. This includes all commercial, legal and interpersonal levels, concerns and aspects.
Learn moreThanks to our extensive network of distribution partners, you can order our products from anywhere in the world. The high degree of satisfaction of our customers speaks for itself. Our aim is to precisely tailor our products to your needs. Rely on our many years of experience, our quality, flexibility and excellent service.
Learn moreToday, we are proud to announce that ZytoVision, our sister company, received the IVDR certification!
The AmoyDx® HANDLE Melanoma NGS Panel is a Next-Generation Sequencing-based assay for the qualitative detection of SNVs and InDels in nine key melanoma genes.
The AmoyDx® Myeloid Blood Cancer Panel enables a comprehensive molecular genetic analysis for the qualitative detection of SNVs, InDels and fusions in 55 genes associated with myeloid leukemia on DNA and RNA.
The AmoyDx® HRD Complete Panel is an advanced development of the AmoyDx® HRD Focus Panel, which is already established in many laboratories for determining homologous recombination deficiency (HRD).